Angewandte Chemie International Edition · 2019 · 76 citations · 24 references
Life SciencesMedicinal ChemistryPharmacologyDrug DesignPolymer ChemistryPolymer MaterialsAmyloid FormationNanomedicinePolymer FunctionalizationPolymerization ChemistryProtein AggregationProtein Aggregation DisordersAmyloid Beta AggregationAmyloid FibrilsAmyloid InhibitionAmyloid PlaquesConjugated PolymersHydrophobic InteractionsInhibition Of Amyloid FormationProtein Aggregates
Protein misfolding and aberrant aggregations are associated with multiple prevalent and intractable diseases. Inhibition of amyloid assembly is a promising strategy for the treatment of amyloidosis. Reported here is the design and synthesis of a reactive conjugated polymer, a poly(p-phenylene vinylene) derivative, functionalized with p-nitrophenyl esters (PPV-NP) and it inhibits the assembly of amyloid proteins, degrades preformed fibrils, and reduces the cytotoxicity of amyloid aggregations in living cells. PPV-NP is attached to the proteins through hydrophobic interactions and irreversible covalent linkage. PPV-NP also exhibited the capacity to eliminate Aβ plaques in brain slices in ex vivo assays. This work represents an innovative attempt to inhibit protein pathogenic aggregates, and may offer insights into the development of therapeutic strategies for amyloidosis.
24
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Jeff Sevigny, Ping Chiao, Thierry Bussière et al. · Nature · 2016 · 3.1K citations
Amyloid pores from pathogenic mutations
Hilal A. Lashuel, Dean M. Hartley, Benjamin M. Petre et al. · Nature · 2002 · 1.3K citations · Full text
Exploiting Amyloid Fibril Lamination for Nanotube Self-Assembly
Kun Ping Lu, Jaby Jacob, P. Thiyagarajan et al. · Journal of the American Chemical Society · 2003 · 355 citations
Xueli Zhang, Yanli Tian, Li Zeng et al. · Journal of the American Chemical Society · 2013 · 349 citations · Full text